Latest Biotech News

Lead: STAT reported criticisms around the FDA’s recently proposed “plausible mechanism pathway,” a regulatory concept intended to streamline approval of personalized, small‑batch gene‑editing...

Lead: AnswersNow closed a $40 million Series B led by HealthQuest Capital, with participation from Left Lane Capital and Owl Ventures, to expand access to autism therapy via its telehealth...

Lead: A team led by Laura Osanno published an analysis in Annals of Hematology examining the toxicity‑to‑efficacy ratio of venetoclax in hematologic malignancies, aiming to predict which patients...

Lead: A preclinical study by Yang et al. described KC1036, a novel small molecule candidate that demonstrated anti‑tumor activity in Ewing sarcoma models and revealed mechanistic insights into its...

Researchers published in Nature Communications (2026) report a Granzyme B-mimetic nanozyme packaged in a targeted nanovesicle that selectively induces cancer-cell death. The team describes...

A new study outlines next-generation CAR-T cell designs that exploit tumor-specific features to increase selectivity and antitumor activity. Researchers describe modular CAR constructs that sense...

Phase II SPARK trial results show objective responses when the tyrosine-kinase inhibitor sitravatinib is combined with the anti–PD-1 antibody tislelizumab in patients with locally recurrent or...

A phase I study reports that adoptive infusion of natural killer (NK) cells is feasible and shows preliminary signals in patients with recurrent hepatocellular carcinoma after liver...

Researchers publishing in Genome Medicine map spatial interactions between GPNMB+ macrophages and COL6A3+ fibroblasts that promote vascular fibrosis in glioblastoma. Using spatial transcriptomics,...

A Molecular Cancer study identifies the deubiquitylase USP7 as a regulator of immune signaling in microsatellite-stable colorectal cancer (MSS CRC). The authors show that USP7 activity suppresses...

Two transcriptome‑wide association studies (TWAS) reported independently uncover new genes causally linked to diabetic nephropathy. Teams used integrated genetic and expression datasets to...

A multicenter cohort study in the Journal of Ovarian Research reports sustained patient‑reported benefits for niraparib as long-term maintenance in platinum‑sensitive recurrent ovarian cancer....

AnswersNow closed a $40 million Series B led by HealthQuest Capital, with participation from Left Lane Capital and Owl Ventures to expand access to autism therapy via its digital service. The...

Qiagen disclosed to advisers that it is evaluating strategic options amid reported interest from potential buyers, according to Bloomberg-sourced coverage; shareholders drove the stock back toward...

Moderna announced it is scaling back investments in vaccine trials, CEO comments reported on Bloomberg TV. The company cited growing political and public resistance in the U.S. to expanded vaccine...

Qiagen confirmed it is assessing strategic options after media reports that the company has held preliminary talks with potential buyers, including U.S. strategics. Bloomberg and other outlets...

Worldwide Clinical Trials agreed to acquire Catalyst Clinical Research, extending consolidation among private-equity-backed contract research organizations (CROs). The deal highlights continued...

AnswersNow closed a $40 million Series B round led by HealthQuest Capital with participation from Left Lane Capital and Owl Ventures to scale access to autism therapy. The company provides remote...

A new study presents engineered CAR-T cells designed to exploit specific tumor characteristics to improve efficacy. Researchers detailed strategies that leverage tumor heterogeneity and...

A phase I clinical trial reported that infusions of natural killer (NK) cells produced promising safety and feasibility signals in patients with recurrent hepatocellular carcinoma after liver...